64 related articles for article (PubMed ID: 1658886)
41. [Treatment with clonidine in a case of the short bowel syndrome with therapy-refractory diarrhea].
Scholz J; Bause H; Reymann A; Dürig M
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Aug; 26(5):265-9. PubMed ID: 1681951
[TBL] [Abstract][Full Text] [Related]
42. Metal and metal-ATP interactions with human platelet adenylate cyclase: effects of alpha adrenergic inhibition.
Jakobs KH; Saur W; Schultz G
Mol Pharmacol; 1978 Nov; 14(6):1073-8. PubMed ID: 32476
[No Abstract] [Full Text] [Related]
43. Uncoupling of the platelet alpha 2-adrenoceptor adenylate cyclase system by N-ethylmaleimide and the resulting effect on receptor density and sensitivity.
García-Sevilla JA; Areso P; Giralt MT; Ulibarri I
Eur J Pharmacol; 1988 Jan; 145(1):91-5. PubMed ID: 2832185
[TBL] [Abstract][Full Text] [Related]
44. Isolation and partial purification of a clonidine-displacing endogenous brain substance.
Atlas D; Burstein Y
Eur J Biochem; 1984 Oct; 144(2):287-93. PubMed ID: 6092070
[TBL] [Abstract][Full Text] [Related]
45. A low molecular weight brain substance interacts, similarly to clonidine, with alpha 2-adrenoceptors of human platelets.
Diamant S; Eldor A; Atlas D
Eur J Pharmacol; 1987 Dec; 144(3):247-55. PubMed ID: 2831067
[TBL] [Abstract][Full Text] [Related]
46. Adenylate cyclase and alpha-2-adrenoceptors in thrombocytes of chronic uremic patients.
Lübbecke F; Sandelbaum J; Schütterle G; Wizemann V
Blood Purif; 1988; 6(5):269-75. PubMed ID: 2846009
[TBL] [Abstract][Full Text] [Related]
47. Decrease in epinephrine-induced attenuation of platelet adenylate cyclase activity in depressed patients: relation with plasma electrolytes.
Karege F; Bovier P; Widmer J; Gaillard JM; Tissot R
Neuropsychobiology; 1992; 26(3):129-35. PubMed ID: 1338221
[TBL] [Abstract][Full Text] [Related]
48. Isolation and characterization of 9-hydroxy-10-trans,12-cis-octadecadienoic acid, a novel regulator of platelet adenylate cyclase from Glechoma hederacea L. Labiatae.
Henry DY; Gueritte-Voegelein F; Insel PA; Ferry N; Bouguet J; Potier P; Sevenet T; Hanoune J
Eur J Biochem; 1987 Dec; 170(1-2):389-94. PubMed ID: 3691528
[TBL] [Abstract][Full Text] [Related]
49. Lithium modulation of second messenger signal amplification in man: inhibition of phosphatidylinositol-specific phospholipase C and adenylate cyclase activity.
Ebstein RP; Lerer B; Bennett ER; Shapira B; Kindler S; Shemesh Z; Gerstenhaber N
Psychiatry Res; 1988 Apr; 24(1):45-52. PubMed ID: 2839860
[TBL] [Abstract][Full Text] [Related]
50. [Thrombocyte adenylate cyclase activity in polycythemia vera].
Egorova VA; Beliaeva VA; Shcherbakov EG; Blinov MN
Probl Gematol Pereliv Krovi; 1977 Nov; (11):36-7. PubMed ID: 594063
[No Abstract] [Full Text] [Related]
51. Genetic studies at the receptor level: investigations in human twins and experimental animals.
Propping P; Friedl W; Hebebrand J; Lentes KU
Ciba Found Symp; 1986; 123():42-56. PubMed ID: 3028728
[TBL] [Abstract][Full Text] [Related]
52. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
Macfarlane DE; Stump DC
Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
[TBL] [Abstract][Full Text] [Related]
53. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
Lenox RH; Ellis J; Van Riper D; Ehrlich YH
Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397
[TBL] [Abstract][Full Text] [Related]
54. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
Turner JT; Ray-Prenger C; Bylund DB
Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671
[TBL] [Abstract][Full Text] [Related]
55. Species differences in alpha 2-adrenergic regulation of platelet adenylate cyclase.
Slotkin TA; McCook EC; Nemeroff CB; Seidler FJ
Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):259-71. PubMed ID: 1658886
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
Watanabe Y; Jakobs KH
Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
[TBL] [Abstract][Full Text] [Related]
57. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
[TBL] [Abstract][Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
